Pharmacogenomics for Drug Dosing in Children: Current Use, Knowledge, and Gaps.
Pharmacogenomics for Drug Dosing in Children: Current Use, Knowledge, and Gaps.
复制标题
儿童药物给药的药物基因组学:目前的使用,知识和差距。
DOI:
10.1002/jcph.1891
复制
发表时间:
2021-06
影响因子:
2.9
通讯作者:
Yang JJ
中科院分区:
文献类型:
--
作者:
Hoshitsuki K;Fernandez CA;Yang JJ
Pharmacogenomics research ranges from the discovery of genetic factors to explain inter-patient variability in drug exposure and response to clinical implementation of this knowledge to improve pharmacotherapy. Medications with actionable pharmacogenomic associations are frequently used in children and therefore pharmacogenomics-guided precision medicine is readily applicable to the pediatric population. Although heritable genetics are considered immutable, the impact of genetic variation in pharmacogenes is modified by other factors, such as age-dependent changes in gene expression. Early evidence has emerged indicating that the interaction between ontogeny and pharmacogenomics determines whether or how genetics-based dosing algorithms should be adjusted in children vs adults. However, there is still a paucity of data describing pharmacogenomic associations in patient populations across the lifespan. Future research is much needed to evaluate the impact of pharmacogenomics on drug dosing specific in pediatric, along with consideration of other developmental and physiological factors uniquely related to drug disposition in this population.
登录
查看更多内容
影响因子:
6.7
作者:
通讯作者:
--
DOI:
10.1111/cts.12931
发表时间:
2021-03
期刊:
Clinical and translational science
影响因子:
--
作者:
Brown JT;Ramsey LB;Van Driest SL;Aka I;Colace SI
通讯作者:
Colace SI
DOI:
10.1056/nejmsr1809937
发表时间:
2019-08-15
期刊:
The New England journal of medicine
影响因子:
--
作者:
All of Us Research Program Investigators;Denny JC;Rutter JL;Goldstein DB;Philippakis A;Smoller JW;Jenkins G;Dishman E
通讯作者:
Dishman E
影响因子:
64.8
作者:
Relling MV;Evans WE
通讯作者:
Evans WE
影响因子:
2.9
作者:
Conklin, Laurie S.;Hoffman, Eric R.;van den Anker, John
通讯作者:
van den Anker, John